AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study

The purpose of this study is to establish the correlation between sample matrices, and to determine the sample stability for the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diagnostic Tests

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitario Virgen de la Arrixaca, Murcia, Spain

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects must be able to understand given information and demonstrate willingness and ability to voluntarily give a signed, valid written informed consent to participate in the study.
Subjects must be 18 years of age or older.
Subjects with expected NT-proBNP concentrations within the measuring range of NTproBNP2 Test Kit.

Exclusion criteria

Subjects known to be pregnant or breast-feeding.
Subjects previously enrolled in the study.
Subject, who has withdrawn consent.

Treatment and study plan

Primary outcomes

Correlation

Time frame: 5 month

To establish a correlation between sample matrices
Stability

Time frame: 5 month

To determine sample stability with the NTproBNP2 Test Kit on the AQT90 FLEX analyzer

Sponsors and collaborators

Lead sponsor

Radiometer Medical ApS

Industry

Registry information

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Apr 1, 2025
Registry last updated: Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed